Clinical trials: Small Lymphocytic Lymppho, open to volunteers

Small Lymphocytic Lymppho, Relapsed/Refractory Chronic Lymphocytic Leukemia

A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

• Not yet recruiting
• Age: 18 years and older
• Phase 3
• Pill or oral medicine
• Injection or infusion

To Evaluate the Efficacy and Safety of TQB3909 Tablets versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Trial name

NCT07753369

Testing

TQB3909 Tablets, Bendamustine Injection, Rituximab injection

Where

2 sites in China

Volunteers

128 people

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.